Cefibax T 500mg/62.5mg Injection
Marketer
Brzee Mediscience
Salt Composition
Ceftriaxone (500mg) + Tazobactum (62.5mg)
Overview Cefibax T 500mg/62.5mg Injection
Cefibax T 500mg/62.5mg injectable solution is a dual-action antibiotic used to combat diverse bacterial infections. Its mechanism involves suppressing microbial proliferation, thus halting infection progression. Administration must always be overseen by a medical practitioner. Strict adherence to the prescribed dosage schedule is crucial; incomplete treatment may compromise efficacy. Typical side effects include nausea, vomiting, diarrhea, and dyspepsia. Any worsening of symptoms necessitates immediate medical attention. Seek urgent medical assistance for allergic reactions (e.g., skin rashes, pruritus, edema, respiratory distress). Prior to use, disclose all current medications and pre-existing conditions to your physician. This is especially important for pregnant or lactating individuals. Alcohol consumption should be avoided due to potential additive sedation. While usually non-impairing, driving should be avoided if drowsiness or dizziness occurs. Optimal recovery involves ample rest, nutritious food, and hydration. Your doctor may order tests to monitor treatment response.
Uses of Cefibax T 500mg/62.5mg Injection
Infections caused by bacteria
Major Benefits of Cefibax T 500mg/62.5mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Cefibax T 500mg/62.5mg Injection:
- Diarrhea
- Increased liver enzymes
- Allergic reaction
- Rash
How to use Cefibax T 500mg/62.5mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strictly prohibited.
How Cefibax T 500mg/62.5mg Injection works:
Ceftriaxone and Tazobactum, combined as Cefibax T 500mg/62.5mg Injection, offer a powerful antibacterial approach. Ceftriaxone, a potent antibiotic, disrupts bacterial cell wall synthesis, hindering bacterial survival. Tazobactum, a beta-lactamase inhibitor, counteracts bacterial resistance mechanisms, thereby optimizing Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
Concurrent use of alcohol and Cefibax T 500mg/62.5mg Injection poses no known adverse reactions.
PregnancySAFE IF PRESCRIBED
The injectable medication Cefibax T 500mg/62.5mg is typically deemed safe for pregnant individuals. Preclinical trials using animals revealed minimal or no negative impacts on fetal development; nevertheless, clinical data from human studies remain scarce.
Breast feedingCAUTION
The administration of Cefibax T 500mg/62.5mg Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued throughout the mother's treatment course and until the medication is fully cleared from her system.
DrivingUNSAFE
Cefibax T 500mg/62.5mg Injection can cause drowsiness, blurred vision, and dizziness. Driving should be avoided if these side effects are experienced.
KidneyCONSULT YOUR DOCTOR
Data on Cefibax T 500mg/62.5mg Injection use in individuals with renal impairment is scarce. Physician consultation is advised.
LiverCAUTION
The 500mg/62.5mg Cefibax T Injection requires careful administration in individuals with severe hepatic impairment; dosage modification may be necessary. Consult your physician for guidance. Dosage alterations for this injection are not advised for patients exhibiting mild or moderate liver dysfunction.
What if you forget to take Cefibax T 500mg/62.5mg Injection :
Should you forget a scheduled dose of Cefibax T 500mg/62.5mg Injection, seek medical advice.
Facts to Know About Cefibax T 500mg/62.5mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Anti-Infectives |
3,018 People bought this recently